TLX 1 Jun 2026, 3:20 PM

Appendix 3Y Change in Director Interest - C Behrenbruch

TELIX Pharmaceuticals Ltd

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in